Audientes A/S Logo

Audientes A/S

Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.

AUDNTS | CO

Overview

Corporate Details

ISIN(s):
DK0061406618
LEI:
984500F69AMF062DF496
Country:
Denmark
Address:
Teknikerbyen 5, 2., 2830 Virum
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Audientes A/S is a Danish hearing health technology company founded in 2014. It specializes in the design, development, and marketing of smart, self-fitting, and affordable hearing aids and advanced hearables. The company's flagship product, Ven™, is a self-fitting hearing aid that allows users to perform a hearing test at home, either through the device's built-in controls or a companion smartphone app. The device then automatically calibrates to the user's personal hearing profile. Designed for adults with mild to severe hearing loss, Audientes' products feature Bluetooth connectivity for calls and music streaming. The company's mission is to make high-quality hearing solutions accessible and affordable globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-15 16:20
Capital/Financing Update
English 123.3 KB
2022-12-20 13:05
Share Issue/Capital Change
English 141.6 KB
2022-11-23 19:18
Prospectus
English 162.7 KB
2022-11-18 20:50
Share Issue/Capital Change
English 169.3 KB
2022-11-16 16:10
Capital/Financing Update
English 110.4 KB
2022-11-14 17:26
Earnings Release
English 131.8 KB
2022-10-11 17:12
AGM Information
English 106.8 KB
2022-09-26 15:30
Pre-Annual General Meeting Information
English 224.7 KB
2022-08-25 11:58
Interim / Quarterly Report
English 7.3 MB
2022-07-19 16:21
Regulatory Filings
English 121.2 KB
2022-07-19 16:20
Earnings Release
English 143.6 KB
2022-07-06 12:45
Delisting Announcement
English 122.4 KB
2022-06-30 16:57
Remuneration Information
English 111.4 KB
2022-06-30 13:03
Regulatory Filings
English 70.8 KB
2022-06-27 16:02
Delisting Announcement
English 118.1 KB

Automate Your Workflow. Get a real-time feed of all Audientes A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Audientes A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Audientes A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France
ALSAF
Sanara MedTech Inc. Logo
Develops med-tech for surgical, wound, and skin care, plus telehealth for providers.
United States of America
SMTI
SANYU CO.,LTD. Logo
A manufacturer of medical analytical equipment focused on R&D for next-generation systems.
Japan
5697
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden
CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden
HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany
1SXP
SD BIOSENSOR  INC. Logo
South Korea
137310
SeaStar Medical Holding Corp Logo
Develops a device-based therapy for hyperinflammation in critically ill ICU patients.
United States of America
ICU
SEJONG MEDICAL Co.Ltd., Logo
South Korea
258830
Senseonics Holdings, Inc. Logo
Develops the first long-term, implantable glucose sensor for diabetes management.
United States of America
SENS

Talk to a Data Expert

Have a question? We'll get back to you promptly.